Sputnik V cleared for launch in India: Five things you need to know about Russian Covid-19 vaccine
Tuesday, 13 April 2021 () Dr Reddy's Laboratories said on Tuesday it has received permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for restricted use in emergency situations. The permission is subject to provisions of New Drug and Clinical Trials Rules 2019 under the Drugs and Cosmetics Act.
Subject Expert Committee of union government on April 12 approved Dr Reddy's application for emergency use authorisation to Russian COVID vaccine 'Sputnik V' in India. With this, India has now three COVID-19 vaccines in use. Welcoming the step, Medical Superintendent of RML Hospital, Dr Rana AK Singh...
Sputnik V is a minus 18-degrees Celsius storage vaccine, informed Ravi Mathur, Global Logistics' Head, Dr Reddy's Laboratories after the Russian vaccines arrived in India on May 01."Sputnik V is a minus 18-degrees Celsius storage vaccine. We have created a state-of-the-art central warehouse that operates below minus 20-degrees Celsius. These are single-dose ampules, once taken out have to be administered within 30 mins," informed Head of global logistics at Dr. Reddy's lab.
The Sputnik V vaccine will be available in a few weeks after statutory clearances, informed Deepak Sapra, CEO of Dr Reddy's Laboratories after the Russian vaccines arrived in India on May 01. "Today, we have received 1,50,000 doses of Sputnik V vaccine here in Hyderabad. The vaccine will be available in a few weeks after it has gone through statutory clearances. The price will also be announced then," said CEO Sapra.
Sputnik V is the Russian made covid vaccine with an efficacy rate above 90%. 150,000 doses of Sputnik have arrived at Hyderabad in India on Saturday. The vaccines will be handed over to Dr Reddy's Laboratories, and soon to be distributed among the healthcare systems of the country.
#covid19 #covid vaccines #SputnikV #Russia #Indiacovidcrisis
Singer Sonu Nigam inaugurated the blood donation camp organised by Ameet Satam's Adarsh Foundation at Bharatmata Hall, Vidyanidhi campus in Juhu. He donated blood and urged his fans to donate blood amid the second wave of COVID-19. The singer became the first blood donor of the two-day camp set up in Juhu and he also motivated the youth to donate blood before taking the vaccination. Sonu Nigam had tested COVID positive earlier.
Tamil Nadu government had imposed fresh COVID-19 restricts in order to curb the spread of the novel coronavirus. Government had also extended night curfew and Sunday lockdowns till further orders. Government-run TASMAC liquor shops have been permitted to operate between 8 am and noon till May 20. Locals thronged the shops on the morning of May 06 to get their dose of alcohol.
In wake of COVID-19 spread, testing has been ramped up by governments. A long queue was seen at Moradabad Railway Station as people waited for health officials to arrive and begin the testing. People complained that they have been standing in queue since morning but administration is delaying the testing process. Later, lab technician informed that due to unavailability of transport, they could not reach on time.
Once again India crossed the 4-lakh mark in daily spike of COVID-19 cases after reporting 4,12,262 new infections in last 24 hours. COVID caseload of the country stood at 2,10,77,410, with 35,66,398 active cases. Death toll continues to mount as India reported highest single day deaths. 3,980 fatalities were reported in last 24 hours taking the total death toll to 23,01,68. Total of 1,72,80,844 people have won the battle against the deadly virus. Vaccination drive is underway across country. So far 16,25,13,339 doses have been administered.
The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults. A release by Cadila Health said, "The drug has also shown efficacy against other viral infections."Speaking on the development, Dr Sharvil Patel, Managing Director, Cadila Healthcare Limited said: "The fact that we are able to offer a therapy which significantly reduces viral load when given early on can help in better disease management. It comes at a much-needed time for patients and we will continue to provide them access to critical therapies in this battle against COVID-19." This government's approval for use of the antiviral drug comes at a time when India's daily COVID tally is crossing the 3-lakh mark. India recorded 3,32,730 new COVID-19 cases in the last 24 hours, the highest single-day spike since the pandemic broke out last year. India has crossed the mark of 3 lakh COVID-19 cases for two consecutive days now. This has taken the cumulative count of the COVID infection in the country to 1,62,63,695.
Calling UK "a solid friend", EAM Dr S Jaishankar on India-UK relationship said that India is getting oxygen plants, oxygen concentrators, cylinders to address the oxygen challenge, cryogenic tanks, and..